Multifidus stimulation: when the deep back muscles stop firing

Most back pain treatment focuses on structures, discs, joints, and bones, but a meaningful subset of chronic low back pain comes from something different: a small, deep muscle that has essentially stopped doing its job properly, independent of any structural damage visible on a scan. This article explains that problem and the treatment developed specifically to address it.

What the multifidus muscle actually does

The multifidus muscles are small, deep muscles running along either side of the spine, with individual segments attaching to each vertebra. Their job is providing fine, segment-by-segment stability to the spine during movement, working constantly in the background rather than producing large, visible movements the way bigger back muscles do.

This deep, stabilising role means the multifidus is active during almost every movement of daily life, bracing each spinal segment appropriately as the body bends, twists, and lifts. When it’s working properly, this happens automatically, without any conscious effort or awareness. This automatic, unconscious quality is part of what makes dysfunction here so easy to overlook; unlike a muscle used for a specific, deliberate movement, most people have never consciously thought about the multifidus at all until something goes wrong with it.

Because of this constant, background role, problems with the multifidus don’t necessarily announce themselves the way a more obviously painful structural problem might; instead, they can show up as a vague sense of the back feeling unstable or unreliable during certain movements, even when imaging looks relatively unremarkable. This vague, hard-to-pin-down quality is one of the more frustrating aspects of this particular problem for patients, since it doesn’t fit neatly into the kind of clear, localised description that makes other back problems easier to explain and investigate.

How chronic pain disrupts this muscle specifically

When back pain occurs, whether from a disc problem, a strain, or another cause, the nervous system can respond by inhibiting the multifidus muscle at that level, a protective reflex that reduces movement at a painful segment in the short term.

In many people, this inhibition resolves naturally once the original pain trigger settles, and the muscle returns to its normal firing pattern. In others, for reasons not entirely understood, the inhibition persists even after the original trigger has resolved, leaving the muscle not firing properly during movement despite no ongoing structural problem. Why this inhibition resolves naturally in some people but persists in others isn’t yet fully understood, and this remains an active area of research, though it is recognised as a genuine clinical phenomenon regardless of the precise underlying explanation.

This persistent dysfunction, sometimes called arthrogenic muscle inhibition, is a genuine, measurable change in motor control, not simply weakness or deconditioning, which is an important distinction because it explains why standard strengthening exercises don’t always fully resolve it, even when performed diligently.

Why this isn’t solved by just strengthening the muscle

Traditional strengthening exercises work by progressively loading a muscle to increase its capacity, which is effective for muscles that are simply weak or deconditioned. Multifidus dysfunction of this specific type is a different problem: the muscle may have reasonable capacity but isn’t being activated at the right time during movement.

This distinction matters practically because someone can diligently perform core strengthening exercises for months without resolving this specific issue, since the exercises may not actually re-establish the muscle’s normal automatic firing pattern during real-world movement, even if they build general strength elsewhere.

Specialised physiotherapy techniques do exist that specifically target this re-education process, and these are generally tried before considering a more involved treatment like stimulation, but they don’t work for everyone, which is part of why a more direct approach has been developed for cases where this re-education doesn’t succeed through exercise alone. These techniques typically involve very precise, low-load exercises designed to isolate and re-engage the multifidus specifically, quite different from more general core exercises that tend to be dominated by larger, more superficial muscles taking over the work instead.

How multifidus stimulation actually works

The treatment involves implanting a small device near the nerve that controls the multifidus muscle at the affected spinal level. Rather than simply strengthening the muscle through exercise, it delivers direct electrical stimulation to the nerve during specific, scheduled daily sessions.

This stimulation directly activates the muscle in a way that bypasses whatever is disrupting its normal nervous system signal, and over a defined treatment period, typically around a year, the goal is retraining the muscle’s normal firing pattern so it resumes working appropriately during everyday movement without needing ongoing stimulation. This is conceptually similar to how certain rehabilitation approaches use electrical stimulation to help retrain other muscles after nerve-related problems elsewhere in the body, applying a comparable principle specifically to this deep spinal stabiliser. The specific device and technique used here, however, are purpose-built for this particular muscle and nerve, rather than adapted general-purpose equipment.

The device is implanted through a minimally invasive procedure, and the daily stimulation sessions are typically brief, fitting into a normal daily routine rather than requiring extended time away from regular activities during the treatment period. Most people are able to return to normal daily activities relatively quickly after the implantation procedure itself, with the ongoing stimulation sessions becoming simply a brief, regular part of the daily routine rather than a significant disruption to work or other commitments.

Who this treatment actually suits

A suitable candidate typically has chronic low back pain without a clearly identified structural cause that would need its own specific treatment, such as a significant disc herniation, spinal instability, or spinal stenosis, since this treatment addresses muscle control specifically rather than a structural problem.

This person has usually tried a reasonable course of physiotherapy, including attempts at the specialised re-education techniques mentioned earlier, without achieving adequate, lasting improvement, and has multifidus dysfunction specifically identified as a contributing factor through clinical assessment. The specific duration and intensity of prior physiotherapy that’s considered a reasonable trial varies somewhat, but the general principle is that genuine, consistent effort with appropriately targeted exercises, not just a brief or generic attempt, should have been made before this treatment becomes the next consideration.

As with basivertebral nerve ablation for a different specific cause of chronic back pain, this is not a treatment for back pain generally; it’s suited to a particular subset of patients where this specific muscle-control problem has been identified as a meaningful contributor to their ongoing symptoms.

Risks and practical considerations

As with any implanted device, there are procedural risks to understand, including the general risks of the implantation procedure itself, a small risk of infection, and the possibility that the device may need adjustment or, rarely, early removal if problems arise during the treatment period.

The daily stimulation sessions require a degree of ongoing engagement from the patient, remembering to complete them consistently over the treatment period, which is a genuinely different commitment from a one-time procedure and is worth considering honestly before proceeding. Setting a consistent daily routine or reminder for these sessions, similar to how one might approach a daily medication schedule, helps ensure the full benefit of the treatment protocol is actually achieved over its full duration.

Not every healthcare system or insurance provider has the same familiarity or coverage policy for this relatively specialised treatment, which makes an early, direct conversation about practical and financial considerations a sensible step before committing to the process. This is worth raising at the very first consultation discussing this option, rather than discovering coverage gaps only after testing has confirmed someone would otherwise be a suitable candidate.

Because this treatment is specifically for multifidus dysfunction rather than a structural problem, confirming this diagnosis accurately beforehand, rather than assuming it based on persistent pain alone, matters considerably for whether the treatment is actually likely to help in a given person’s situation. Persistent pain alone, without the specific functional testing described elsewhere confirming multifidus involvement, is not a sufficient basis for pursuing this particular option over other possibilities.

What the evidence shows, and what recovery looks like

Clinical trials studying this treatment in appropriately selected patients have shown meaningful improvements in both pain and functional measures, and notably, some studies have found these improvements were sustained even after the device was removed at the end of the treatment period.

This sustained benefit after removal is a particularly meaningful finding, since it suggests the treatment achieves something more durable than simply masking symptoms during active stimulation; it supports the idea that the muscle’s normal control pattern can genuinely be retrained and then maintained independently afterward. This distinguishes it conceptually from treatments that only provide relief while actively being used, since the goal here is a lasting change in how the muscle functions, verified by the fact that benefits persisted in trial participants after the device was no longer active.

As with any treatment, individual results vary, and the appropriately selected patient group in clinical trials doesn’t guarantee the same outcome for every single person, which is why ongoing assessment throughout the treatment period, rather than a single decision point, remains part of how this treatment is actually delivered. Regular check-ins during the treatment year allow adjustments to the stimulation protocol or additional guidance on movement patterns, rather than leaving the device to work in isolation without any clinical support along the way.

How this fits alongside other chronic back pain treatments

This treatment occupies a specific niche within the broader landscape of chronic low back pain care, distinct from structural treatments like disc surgery or facet joint procedures, and distinct from the vertebrogenic pain addressed by basivertebral nerve ablation, since it targets a motor control problem rather than a structural or bone-related source.

Correctly distinguishing between these different possible sources of chronic low back pain, a disc problem, a facet joint issue, vertebrogenic pain, or multifidus dysfunction, is genuinely the most important step for anyone with persistent symptoms that haven’t responded to initial conservative treatment, since each points toward a different, specific next step.

A thorough assessment by a spine specialist, rather than a single generic diagnosis of “chronic low back pain,” is what actually identifies which of these specific categories, or combination of them, is driving an individual’s symptoms, which in turn determines whether this particular treatment, among several available options, is actually relevant.

For anyone who has tried standard physiotherapy and core strengthening without success, and who hasn’t had multifidus function specifically assessed, raising this possibility directly with a spine specialist is a reasonable next step before assuming no further options remain.

How multifidus dysfunction is actually identified

Specific clinical tests can assess whether the multifidus is firing appropriately during particular movements, often involving real-time ultrasound imaging that lets a clinician directly observe the muscle contracting, or failing to contract properly, as the patient performs specific tasks.

This kind of assessment is different from a standard MRI, which shows the muscle’s size and structure but doesn’t directly show how well it’s actually functioning during movement, which is why a normal-looking muscle on imaging doesn’t rule out this specific kind of functional problem.

A detailed movement assessment by a physiotherapist experienced in this specific area can often identify telltale signs of multifidus dysfunction even without specialised imaging, such as particular patterns of compensation from other muscles during movements that should normally be stabilised by the multifidus itself. Recognising these compensation patterns requires specific training and experience, which is why this kind of assessment is generally more useful coming from a physiotherapist with particular expertise in this area rather than a general exercise programme.

Combining this functional assessment with imaging that has already reasonably ruled out a significant structural cause builds a more complete picture, and it’s this combination, rather than any single test, that typically supports a confident diagnosis of multifidus dysfunction as the primary contributor to someone’s chronic pain. This combined approach reflects the same broader principle seen throughout chronic back pain care: accurate diagnosis usually depends on triangulating several pieces of information rather than relying on one test to provide a complete answer on its own.